Israeli Cannabis Pharm Company Partners With Nebulizer Developer

December 12, 2017 | Israeli cannabis pharmaceutical company iCan: Israel-Cannabis has joined forces with respiratory device maker Aura Medical to bring nebulizers to the global medical cannabis market. Aura Medical’s portable nebulizer, treating asthma and Chronic Obstructive Pulmonary Disease (COPD) with controlled dosages of medical cannabis, will be rebranded as “Nebican.” The Nebican is designed with Vibrating Mesh Technology. Through its delivery platform, it emits vapor from the inhaler which quickly enters the lungs. According to Aura Medical CEO Connie Lefkowitz, the nebulizer was used only for certain prescription medicines with “targeted formulation” from Ci Therapeutics, an iCan and CannRx partnership. Nebican is expected to launch in California in mid-2018 followed by the Canadian market afterward.